IL17A and type 2 diabetes mellitus: As detailed in Table 4, the T2DM + NAFLD cohort demonstrated statistically elevated concentrations of IL-6, IL-10, and IFN-γ compared to mono disease cohorts, whereas the concentrations of IL-2, IL-4, and IL-17 were reduced.